FUJIF Earnings Preview: May 8, 2026 – EPS & Revenue Estimates

FUJIFILM Holdings Corporation (FUJIF) will report earnings on May 8, 2026, with analysts expecting $0.3813 EPS and $5.50 billion in revenue. The industrial conglomerate faces a challenging backdrop after stock price declined 11.2% recently, trading at $17.00. FUJIFILM’s diversified portfolio spans healthcare, imaging, materials, and business innovation segments. Meyka AI rates FUJIF with a grade of B+, reflecting solid fundamentals despite recent headwinds. Investors should examine whether the company can maintain earnings momentum amid market pressures and deliver results aligned with analyst expectations.

FUJIF Earnings Estimates vs. Historical Performance

Analysts project FUJIF will report $0.3813 EPS and $5.50 billion revenue for the upcoming quarter. This represents a critical test after mixed recent results. Looking at the last four quarters, FUJIF showed inconsistent earnings performance. In February 2026, the company beat EPS estimates with $0.3873 actual vs. $0.3773 expected, while revenue also exceeded at $5.47 billion vs. $5.39 billion estimated. However, August 2025 results showed a miss, with $0.3079 EPS vs. $0.3048 expected, though revenue came in lower at $5.18 billion vs. $5.26 billion estimated. The May 2025 quarter delivered a strong beat with $0.4411 EPS, significantly outperforming the $0.3596 estimate.

EPS Trend Analysis

Earnings per share have fluctuated between $0.3048 and $0.4411 over the past year. The current $0.3813 estimate sits in the middle range, suggesting analysts expect normalized performance. FUJIF’s ability to beat or miss will depend on operational efficiency and segment profitability. The company’s 11.7% PE ratio indicates relatively attractive valuation compared to historical levels, but recent stock weakness raises questions about investor confidence.

Revenue Consistency Check

Revenue estimates of $5.50 billion align closely with recent quarters, ranging from $5.18 billion to $5.80 billion. This suggests stable demand across FUJIF’s business segments. The $5.47 billion revenue in February 2026 demonstrates the company’s ability to generate consistent top-line growth. However, the 11.2% stock decline suggests market concerns about profitability or guidance rather than revenue generation.

Beat or Miss Prediction Based on Historical Patterns

FUJIF’s earnings track record shows a 50/50 beat-miss pattern over the last four quarters, making this earnings report unpredictable. The company beat on EPS in February 2026 and May 2025, but missed in August 2025. This inconsistency reflects operational challenges or external market factors affecting quarterly performance. Given the recent stock price weakness and analyst caution, the market may be pricing in a potential miss.

Factors Favoring a Beat

FUJIFILM’s strong February 2026 results demonstrate execution capability. The company’s diversified business model across healthcare, imaging, and materials provides multiple revenue streams. Healthcare segment growth, particularly in biomedical services, could drive upside. Additionally, the 2.69% dividend yield suggests management confidence in cash generation, which typically precedes positive earnings surprises.

Factors Suggesting a Miss

The 11.2% recent stock decline and -11.23% one-day change indicate investor pessimism. Technical indicators show RSI at 32.56, signaling oversold conditions but also reflecting negative sentiment. The company’s free cash flow per share of -$108.43 raises concerns about capital efficiency. If FUJIF faces margin pressure or segment weakness, results could disappoint despite revenue meeting estimates.

Key Metrics and What Investors Should Watch

Beyond headline numbers, investors should focus on segment performance, margin trends, and cash flow generation. FUJIF’s gross profit margin of 40.5% and operating margin of 10.8% provide context for profitability. The company’s ROE of 10.4% and ROA of 4.6% show moderate efficiency, but there’s room for improvement. Watch for any commentary on healthcare segment momentum, which represents a growth driver for the company.

Segment Breakdown to Monitor

The Healthcare segment, including biomedical contract manufacturing and pharmaceuticals, should show strong growth. The Materials segment, serving semiconductor and display industries, faces cyclical headwinds. The Business Innovation segment, focused on office equipment and document services, may struggle in a digital-first environment. Management guidance on these segments will be critical for assessing future earnings trajectory.

Cash Flow and Capital Allocation

FUJIFILM’s operating cash flow per share of $332.84 demonstrates solid cash generation despite negative free cash flow. The company’s debt-to-equity ratio of 0.31 provides financial flexibility. Investors should listen for capital allocation plans, including R&D investments in healthcare and imaging technologies. The $71.40 dividend per share reflects commitment to shareholder returns, but sustainability depends on earnings quality.

Meyka AI Grade and Market Outlook

Meyka AI rates FUJIF with a grade of B+, reflecting balanced fundamentals despite recent market weakness. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating suggests FUJIF remains a reasonable value at current prices, though not without risks. The company’s $20.49 billion market cap and 1.21 billion shares outstanding provide liquidity for institutional investors.

Technical Setup and Price Targets

FUJIFILM trades at $17.00, down from $26.42 year high but above $17.00 year low. The 50-day moving average of $19.44 and 200-day average of $21.37 show downtrend pressure. Bollinger Bands upper level at $21.69 suggests potential resistance if the stock recovers. The 12.06 PE ratio remains attractive compared to historical averages, offering value for patient investors. However, technical indicators including MACD at -0.41 and CCI at -147.21 signal continued weakness in the near term.

Analyst Consensus and Forecast

Analyst consensus leans cautiously optimistic, supporting the B+ grade. The company’s five-year revenue growth of 38% and three-year net income growth of 23.5% demonstrate long-term value creation. However, near-term forecasts show modest price appreciation, with yearly forecast of $20.40 and three-year forecast of $19.52, suggesting limited upside from current levels. Earnings execution on May 8 will be critical for restoring investor confidence.

Final Thoughts

FUJIFILM Holdings faces a pivotal earnings report on May 8, 2026, with $0.3813 EPS and $5.50 billion revenue estimates. The company’s mixed beat-miss history and recent 11.2% stock decline create uncertainty, though the B+ Meyka AI grade suggests underlying value. Investors should focus on segment performance, margin trends, and management guidance rather than headline numbers alone. FUJIF’s diversified business model and 2.69% dividend yield provide downside support, but execution on healthcare growth and operational efficiency will determine whether the stock can recover from recent weakness. The May 8 earnings call will reveal management’s confidence in navigating industrial sector headwinds.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.